USH1C
USH1C is a gene that encodes the protein harmonin, which is involved in the function of hair cells in the inner ear. Mutations in this gene are associated with Usher syndrome, a condition characterized by partial or total hearing loss and vision loss.
Function[edit]
The USH1C gene provides instructions for making a protein called harmonin. Harmonin is part of a group of proteins that are important for the development and maintenance of hair cells in the inner ear. These cells are essential for converting sound waves into electrical signals that are interpreted by the brain as sound, a process known as mechanoelectrical transduction.

Harmonin is thought to play a role in the organization of the hair cell's stereocilia, which are hair-like projections that are crucial for hearing. It interacts with other proteins to form a complex that helps maintain the structure and function of these cells.
Clinical Significance[edit]
Mutations in the USH1C gene are known to cause Usher syndrome type 1C, a form of Usher syndrome that is particularly prevalent in the Acadian population of Louisiana. This condition is characterized by profound congenital deafness, progressive vision loss due to retinitis pigmentosa, and balance problems.
Research[edit]
Research into USH1C and its associated protein harmonin is ongoing, with studies focusing on understanding the precise mechanisms by which mutations lead to the symptoms of Usher syndrome. There is also interest in developing gene therapy approaches to correct these mutations and restore function.
Related Pages[edit]
USH1C[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian